Literature DB >> 23110921

Correction: Inducible Cre transgenic mouse strain for skeletal muscle-specific gene targeting.

John J McCarthy1, Ratchakrit Srikuea, Tyler J Kirby, Charlotte A Peterson, Karyn A Esser.   

Abstract

Entities:  

Year:  2012        PMID: 23110921      PMCID: PMC3534611          DOI: 10.1186/2044-5040-2-22

Source DB:  PubMed          Journal:  Skelet Muscle        ISSN: 2044-5040            Impact factor:   4.912


× No keyword cloud information.

Skeletal Muscle 2012, 2:8 http://dx.doi.org/10.1186/2044-5040-2-8. The electronic version of this article is the complete one and can be found online at: http://www.skeletalmusclejournal.com/content/2/1/8. Correction Upon publication of this work [1], it was brought to our attention that the reverse primer sequence for genotyping of HSA-MCM pups was incorrect. The correct reverse primer sequence is 5′-CGACCGGCAAACGGACAGAAGC −3′.
  1 in total

1.  Inducible Cre transgenic mouse strain for skeletal muscle-specific gene targeting.

Authors:  John J McCarthy; Ratchakrit Srikuea; Tyler J Kirby; Charlotte A Peterson; Karyn A Esser
Journal:  Skelet Muscle       Date:  2012-05-07       Impact factor: 4.912

  1 in total
  3 in total

1.  Muscle-derived interleukin 6 increases exercise capacity by signaling in osteoblasts.

Authors:  Subrata Chowdhury; Logan Schulz; Biagio Palmisano; Parminder Singh; Julian M Berger; Vijay K Yadav; Paula Mera; Helga Ellingsgaard; Juan Hidalgo; Jens Brüning; Gerard Karsenty
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

2.  CORP: Using transgenic mice to study skeletal muscle physiology.

Authors:  C Brooks Mobley; Ivan J Vechetti; Taylor R Valentino; John J McCarthy
Journal:  J Appl Physiol (1985)       Date:  2020-02-27

3.  Lack of Tgfbr1 and Acvr1b synergistically stimulates myofibre hypertrophy and accelerates muscle regeneration.

Authors:  Michèle M G Hillege; Andi Shi; Ricardo A Galli; Gang Wu; Philippe Bertolino; Willem M H Hoogaars; Richard T Jaspers
Journal:  Elife       Date:  2022-03-24       Impact factor: 8.713

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.